Teva- Pharmaceutical Industries's current cash is $3.7B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), TEVA shows a current cash of $3.7B. That compares with $1.7B in the prior-year period — up 120.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TEVA's current cash is now $3.7B (was $1.7B) — a 120.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.
Tracking TEVA's current cash over time shows whether Teva- Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7B That compares with $1.7B in the prior-year period — up 120.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $3.7B) with ownership activity and broader fundamentals.
Teva- Pharmaceutical Industries's current cash is $3.7B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.